Calendar

A Pre-Approval Information Exchange (PIE) Webinar sponsored by Seagen, Inc. 

We will provide information about unresectable or metastatic colorectal cancer, followed by an introduction to the clinical data for tucatinib and trastuzumab, an investigational regimen for the treatment of adult patients with HER2-positive colorectal cancer who have received at least one prior treatment regimen for unresectable or metastatic disease.

Tucatinib is under investigation in this indication and has not received FDA approval. The safety and effectiveness of this product for this indication have not been established.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this
webinar, you must be registered as a user of FormularyDecisions^®.

This webinar will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to managed care and specialty pharmacy professionals.

A Pre-Approval Information Exchange (PIE) Webinar sponsored by CSL Behring.

The Hemophilia B Gene Therapy Preapproval Information Exchange will provide information as it relates to etranacogene dezaparvovec, an investigational therapy that has not been approved by the US Food and Drug Association (FDA) for any use. Safety and effectiveness have not been established. This prepapproval information exchange has been prepared in accordance with FDA guidance for industry on communications with payers, formulary committees, or similar entities.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this
webinar, you must be registered as a user of FormularyDecisions^®.

To support payer needs related to the U.S. Food and Drug Administration's (FDA) Accelerated Approval and maintain patient access to critical medications, AMCP held a multi-stakeholder Partnership Forum in Alexandria, VA, November 18-19, 2021. The Partnership Forum included 37 experts from payers, pharmacy benefit managers, integrated delivery systems organizations along with patient advocates, academicians, and other key stakeholders from managed care settings.